Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 4
2019 5
2020 1
2021 6
2022 9
2023 6

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Rosenberger WF, Uschner D, Wang Y. Rosenberger WF, et al. Among authors: uschner d. Stat Med. 2019 Jan 15;38(1):27-30. doi: 10.1002/sim.7978. Stat Med. 2019. PMID: 30537122 No abstract available.
Breakthrough SARS-CoV-2 Infections after Vaccination in North Carolina.
Uschner D, Bott M, Lagarde WH, Keating J, Tapp H, Berry AA, Seals AL, Munawar I, Schieffelin J, Yukich J, Santacatterina M, Gunaratne M, Fette LM, Burke B, Strylewicz G, Edelstein SL, Ahmed A, Miller K, Sanders JW, Herrington D, Weintraub WS, Runyon MS, On Behalf Of The Covid-Community Research Partnership. Uschner D, et al. Vaccines (Basel). 2022 Nov 13;10(11):1922. doi: 10.3390/vaccines10111922. Vaccines (Basel). 2022. PMID: 36423018 Free PMC article.
A roadmap to using randomization in clinical trials.
Berger VW, Bour LJ, Carter K, Chipman JJ, Everett CC, Heussen N, Hewitt C, Hilgers RD, Luo YA, Renteria J, Ryeznik Y, Sverdlov O, Uschner D; Randomization Innovative Design Scientific Working Group. Berger VW, et al. Among authors: uschner d. BMC Med Res Methodol. 2021 Aug 16;21(1):168. doi: 10.1186/s12874-021-01303-z. BMC Med Res Methodol. 2021. PMID: 34399696 Free PMC article. Clinical Trial.
Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March-October, 2021.
Plumb ID, Fette LM, Tjaden AH, Feldstein L, Saydah S, Ahmed A, Link-Gelles R, Wierzba TF, Berry AA, Friedman-Klabanoff D, Larsen MP, Runyon MS, Ward LM, Santos RP, Ward J, Weintraub WS, Edelstein S, Uschner D. Plumb ID, et al. Among authors: uschner d. Vaccine. 2023 Apr 6;41(15):2596-2604. doi: 10.1016/j.vaccine.2023.03.006. Epub 2023 Mar 9. Vaccine. 2023. PMID: 36932031 Free PMC article.
Analysis of accumulated SARS-CoV-2 seroconversion in North Carolina: The COVID-19 Community Research Partnership.
Williamson JC, Wierzba TF, Santacatterina M, Munawar I, Seals AL, Pittman Ballard CA, Alexander-Miller M, Runyon MS, McCurdy LH, Gibbs MA, Ahmed A, Lagarde WH, Maguire PD, King-Thiele R, Hamrick T, Ihmeidan A, Henderson S, Gallaher TR, Uschner D, Edelstein SL, Herrington DM, Sanders JW; North Carolina sites of the COVID-19 Community Research Partnership. Williamson JC, et al. Among authors: uschner d. PLoS One. 2022 Mar 18;17(3):e0260574. doi: 10.1371/journal.pone.0260574. eCollection 2022. PLoS One. 2022. PMID: 35302997 Free PMC article.
27 results